Advanced Metastatic Castration Resistant Prostate Cancer clinical trials

Explore recruiting advanced metastatic castration resistant prostate cancer clinical trials.

Recruiting advanced metastatic castration resistant prostate cancer studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advanced Metastatic Castration Resistant Prostate Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

First-in-human study of 225Ac-PSMA-Trillium (BAY 3563254) in participants with advanced metastatic castration-resistant prostate cancer (mCRPC)

Belgium, Finland, Italy, Sweden, Netherlands

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A study to learn how safe the study treatment actinium-225-macropa-pelgifatamab (BAY3546828) is, how it affects the body, how it moves into, through and out of the body, and about its anticancer activity in men with advanced metastatic castration-resistant prostate cancer (mCRPC)

Finland, Netherlands, Italy, Sweden

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Advanced Metastatic Castration Resistant Prostate Cancer trials by city

Advanced Metastatic Castration Resistant Prostate Cancer clinical trials

Recruiting advanced metastatic castration resistant prostate cancer studies right now

Dual-target PSMA/PSCA CAR-NK Cells in Advanced Prostate Cancer

A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer

A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

A Study to Evaluate the Safety and Drug Levels of ASP5541 in Chinese Participants With Prostate Cancer

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

Study of PF-07248144 in Advanced or Metastatic Solid Tumors

64Cu-GRIP B in Patients With Advanced Malignancies

Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

ARTEMIS-003: HS-20093 in Patients With Metastatic Castrate-resistant Prostate Cancer (mCRPC) and Advanced Solid Tumors

A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate Cancer

Also recruiting in Europe

First-in-human study of 225Ac-PSMA-Trillium (BAY 3563254) in participants with advanced metastatic castration-resistant prostate cancer (mCRPC)

A study to learn how safe the study treatment actinium-225-macropa-pelgifatamab (BAY3546828) is, how it affects the body, how it moves into, through and out of the body, and about its anticancer activity in men with advanced metastatic castration-resistant prostate cancer (mCRPC)

Advanced Metastatic Castration Resistant Prostate Cancer trials by city

Other conditions